How BIO-Europe is expanding beyond dealmaking in 2026

The life sciences industry has always had one great meeting place, a few days in November where the deals get done, the partnerships form, and the direction of the industry quietly shifts. For more than three decades, that place has been BIO-Europe.But this year, something is changing. BIO-Europe has always been the destination for BD professionals and dealmakers. In 2026, it's expanding — broadening its scope to become what the organisers are calling the epicenter of biotech, with new content tracks covering regulatory strategy, clinical development, and manufacturing, new registration options, and a deliberate push to bring the entire biopharma C-suite into the BIO-Europe room.·  01:39 BIO-Europe's 32nd edition: what has kept it relevant ·  05:28 The "epicenter of biotech"·  11:06 From three content tracks to seven ·  13:31 Three new tracks: regulatory, clinical, and biomanufacturing ·  15:45 The new content-only registration pass ·  18:12 Why Cologne and what the city offers the event ·  19:48 The social program at BIO-Europe·  24:54 Where to register and find more informationThis episode is presented with the support of the EBD Group. Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here! Stay updated by subscribing to our newsletterTo dive deeper into the topic: How to succeed at BIO-Europe: DISCO Pharma takes us behind the scenesMeet Fusix Biotech: 2025 BIO-Europe Startup Spotlight champion revolutionizing oncologyLisbon is calling: the BIO-Europe Startup Spotlight returns in March 2026